{"component": "clause", "props": {"groups": [{"snippet": "(v) Healthwatch England and Local Healthwatch; (vi) the General Medical Council; (vii) the General Dental Council; (viii) the General Optical Council; (ix) the General Pharmaceutical Council; (x) the Healthcare Safety Investigation Branch; and (xi) the Information Commissioner; Relevant Information means the Personal Data and Non-Personal Data processed under the Delegation and this Agreement, and includes, where appropriate, \u201cconfidential patient information\u201d (as defined under section 251 of the NHS Act), and \u201cpatient confidential information\u201d as defined in the 2013 Report, The Information Governance Review \u2013 \u201cTo Share or Not to Share?\u201d);", "samples": [{"hash": "aQZgdJltBNy", "uri": "/contracts/aQZgdJltBNy#nice", "label": "Delegation Agreement", "score": 31.4988212585, "published": true}, {"hash": "7Z4t0A82p3w", "uri": "/contracts/7Z4t0A82p3w#nice", "label": "Delegation Agreement", "score": 31.4331226349, "published": true}, {"hash": "3bzXq1UULyp", "uri": "/contracts/3bzXq1UULyp#nice", "label": "Delegation Agreement", "score": 31.4331226349, "published": true}], "size": 15, "snippet_links": [{"key": "local-healthwatch", "type": "definition", "offset": [28, 45]}, {"key": "general-medical-council", "type": "definition", "offset": [56, 79]}, {"key": "dental-council", "type": "definition", "offset": [99, 113]}, {"key": "safety-investigation", "type": "clause", "offset": [211, 231]}, {"key": "information-commissioner", "type": "definition", "offset": [253, 277]}, {"key": "relevant-information", "type": "definition", "offset": [279, 299]}, {"key": "the-personal-data", "type": "definition", "offset": [306, 323]}, {"key": "personal-data-processed", "type": "clause", "offset": [332, 355]}, {"key": "this-agreement", "type": "clause", "offset": [381, 395]}, {"key": "where-appropriate", "type": "definition", "offset": [411, 428]}, {"key": "confidential-patient-information", "type": "clause", "offset": [431, 463]}, {"key": "nhs-act", "type": "definition", "offset": [502, 509]}, {"key": "patient-confidential-information", "type": "definition", "offset": [517, 549]}, {"key": "information-governance", "type": "definition", "offset": [586, 608]}], "hash": "c4d4baf8220e3833d8f7c1c74d62865a", "id": 1}, {"snippet": "(v) Healthwatch England and Local Healthwatch; (vi) the General Medical Council; (vii) the General Dental Council; (viii) the General Optical Council; (ix) the General Pharmaceutical Council; (x) the Healthcare Safety Investigation Branch; and (xi) the Information Commissioner;", "samples": [{"hash": "kPzP1rGT30Q", "uri": "/contracts/kPzP1rGT30Q#nice", "label": "Joint Working Agreement", "score": 34.1831692273, "published": true}, {"hash": "4owwy55MRbw", "uri": "/contracts/4owwy55MRbw#nice", "label": "Joint Working Agreement", "score": 34.1831692273, "published": true}, {"hash": "6E1VPI7uNsk", "uri": "/contracts/6E1VPI7uNsk#nice", "label": "Joint Working Agreement", "score": 33.9223136902, "published": true}], "size": 4, "snippet_links": [{"key": "local-healthwatch", "type": "definition", "offset": [28, 45]}, {"key": "general-medical-council", "type": "definition", "offset": [56, 79]}, {"key": "dental-council", "type": "definition", "offset": [99, 113]}, {"key": "safety-investigation", "type": "clause", "offset": [211, 231]}, {"key": "information-commissioner", "type": "definition", "offset": [253, 277]}], "hash": "0aaa39010c982f4f6cde4b8cf3f2d8fc", "id": 2}, {"snippet": "Locally defined objectives include: \u2022 Delivery of efficiencies to address the Health and Social Care financial challenge.", "samples": [{"hash": "jfKW3TrSdL6", "uri": "/contracts/jfKW3TrSdL6#nice", "label": "Partnership Agreement", "score": 32.0900917053, "published": true}, {"hash": "h8XZC3f0ylX", "uri": "/contracts/h8XZC3f0ylX#nice", "label": "Partnership Agreement", "score": 23.5776863098, "published": true}], "size": 3, "snippet_links": [{"key": "delivery-of", "type": "clause", "offset": [38, 49]}, {"key": "health-and-social-care", "type": "clause", "offset": [78, 100]}], "hash": "ad6a584842175d5836e26b3892d7a763", "id": 3}, {"snippet": "Attention deficit hyperactivity disorder: diagnosis and management. NICE guideline [NG87]Published date: 14 March 2018 Last updated: 13 September 2019. Available at: \u2587\u2587\u2587\u2587\u2587://\u2587\u2587\u2587.\u2587\u2587\u2587\u2587.\u2587\u2587\u2587.\u2587\u2587/guidance/ng87 [Accessed June 2020] NICE. Attention deficit hyperactivity disorder in children and young people: guanfacine prolonged-release. Evidence summary [ESNM70] 22 March 2016. Available at: \u2587\u2587\u2587\u2587\u2587://\u2587\u2587\u2587.\u2587\u2587\u2587\u2587.\u2587\u2587\u2587.\u2587\u2587/advice/esnm70/chapter/Key-points-from-the-evidence [Accessed May 2020]", "samples": [{"hash": "1Z2j2fJucgF", "uri": "/contracts/1Z2j2fJucgF#nice", "label": "Shared Care Agreement", "score": 25.2067070007, "published": true}, {"hash": "9n3TFJfqsL6", "uri": "/contracts/9n3TFJfqsL6#nice", "label": "Shared Care Agreement", "score": 24.5770015717, "published": true}], "size": 2, "snippet_links": [{"key": "march-2018", "type": "clause", "offset": [108, 118]}, {"key": "last-updated", "type": "definition", "offset": [119, 131]}, {"key": "september-2019", "type": "clause", "offset": [136, 150]}, {"key": "available-at", "type": "definition", "offset": [152, 164]}, {"key": "june-2020", "type": "clause", "offset": [214, 223]}, {"key": "children-and-young-people", "type": "clause", "offset": [275, 300]}, {"key": "march-2016", "type": "clause", "offset": [361, 371]}, {"key": "may-2020", "type": "clause", "offset": [472, 480]}], "hash": "3d5ce57ab1e2f082230fc11b17e7f26d", "id": 4}, {"snippet": "Maintenance and monitoring for people taking medication for ADHD. Last Updated September 2019. Available at: \u2587\u2587\u2587\u2587\u2587://\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587\u2587.\u2587\u2587\u2587.\u2587\u2587/pathways/attention-deficit-hyperactivity-disorder#path=view%3A/pathways/attention-deficit-hyperactivity-disorder/maintenance-and-monitoring-for-people-taking-medication-for-adhd.xml&content=view-info-category%3Aview-resources-menu [Accessed June 2020] Joint Formulary Committee. British National Formulary for Children (BNFc). May 2020 Available at: \u2587\u2587\u2587\u2587\u2587://\u2587\u2587\u2587\u2587.\u2587\u2587\u2587\u2587.\u2587\u2587\u2587.\u2587\u2587/ [Accessed May 2020] Electronic Medicines Compendium. Summaries of Product Characteristics. Available at: \u2587\u2587\u2587\u2587\u2587://\u2587\u2587\u2587.\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587.\u2587\u2587/emc [Accessed June 2020] General Medical Council. Prescribing Unlicensed Medicines. Available at: \u2587\u2587\u2587\u2587\u2587://\u2587\u2587\u2587.\u2587\u2587\u2587-\u2587\u2587.\u2587\u2587\u2587/ethical-guidance/ethical-guidance-for-doctors/prescribing-and-managing-medicines-and-devices/prescribing-unlicensed-medicines [Accessed 17.6.20] NHS England. Responsibility for prescribing between Primary & Secondary/Tertiary Care. Publications Gateway Reference 07573. January 2018. Available at: \u2587\u2587\u2587\u2587\u2587://\u2587\u2587\u2587.\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587.\u2587\u2587/wp-content/uploads/2018/03/responsibility-prescribing-between-primary-secondary-care-v2.pdf [Accessed June 2020]", "samples": [{"hash": "1Z2j2fJucgF", "uri": "/contracts/1Z2j2fJucgF#nice", "label": "Shared Care Agreement", "score": 25.2067070007, "published": true}, {"hash": "9n3TFJfqsL6", "uri": "/contracts/9n3TFJfqsL6#nice", "label": "Shared Care Agreement", "score": 24.5770015717, "published": true}], "size": 2, "snippet_links": [{"key": "maintenance-and-monitoring", "type": "clause", "offset": [0, 26]}, {"key": "last-updated", "type": "definition", "offset": [66, 78]}, {"key": "september-2019", "type": "clause", "offset": [79, 93]}, {"key": "available-at", "type": "definition", "offset": [95, 107]}, {"key": "june-2020", "type": "clause", "offset": [379, 388]}, {"key": "formulary-committee", "type": "definition", "offset": [396, 415]}, {"key": "national-formulary", "type": "clause", "offset": [425, 443]}, {"key": "for-children", "type": "clause", "offset": [444, 456]}, {"key": "may-2020", "type": "clause", "offset": [465, 473]}, {"key": "product-characteristics", "type": "clause", "offset": [580, 603]}, {"key": "general-medical-council", "type": "definition", "offset": [673, 696]}, {"key": "nhs-england", "type": "clause", "offset": [914, 925]}, {"key": "responsibility-for", "type": "clause", "offset": [927, 945]}, {"key": "tertiary-care", "type": "definition", "offset": [986, 999]}], "hash": "12445b95ab4c4db566c258a63f3ca0d7", "id": 5}, {"snippet": "COVID-19 rapid guideline: managing the long-term effects of COVID- 19. NG188. 2020. Accessed 29.04.21: \u2587\u2587\u2587\u2587\u2587://\u2587\u2587\u2587.\u2587\u2587\u2587\u2587.\u2587\u2587\u2587.\u2587\u2587/guidance/NG188 6. ONS (2020) The prevalence of long COVID symptoms and COVID-19 complications. Accessed 29.04.21: \u2587\u2587\u2587\u2587\u2587://\u2587\u2587\u2587.\u2587\u2587\u2587.\u2587\u2587\u2587.\u2587\u2587/news/statementsandletters/theprevalenceoflongcovid symptomsandcovid19complications 7. \u2587\u2587\u2587\u2587\u2587 CH, \u2587\u2587\u2587\u2587\u2587\u2587 B, \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 T, \u2587\u2587\u2587\u2587\u2587\u2587 MS, \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587, \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587, et al. Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. medRxiv [Internet]. 2020.10.19.20214494. Accessed 29.04.21: \u2587\u2587\u2587\u2587://\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587/content/early/2020/10/21/2020.10.19.20214494.abstract 8. Tenforde M, \u2587\u2587\u2587 \u2587, \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 C, al. e (2020) Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID- 19 in a Multistate Health Care Systems Network \u2014 United States, MMWR Morb Mortal Wkly Rep. 2020;ePub: Accessed 29.04.21 \u2587\u2587\u2587\u2587://\u2587\u2587.\u2587\u2587\u2587.\u2587\u2587\u2587/10.15585/mmwr.mm6930e1external", "samples": [{"hash": "9uzUOX1XuWI", "uri": "/contracts/9uzUOX1XuWI#nice", "label": "Service Specification", "score": 24.8453121185, "published": true}], "size": 1, "snippet_links": [{"key": "duration-and", "type": "clause", "offset": [739, 751]}, {"key": "risk-factors", "type": "clause", "offset": [752, 764]}, {"key": "return-to", "type": "clause", "offset": [777, 786]}, {"key": "health-care", "type": "clause", "offset": [849, 860]}, {"key": "united-states", "type": "clause", "offset": [879, 892]}], "hash": "c87fbb2faa2aca431daaf0cb8b8111f2", "id": 6}, {"snippet": "4.1.1 The Provider will have systems in place, as relevant and applicable, that ensure the Service is delivered in accordance with current and emerging practice", "samples": [{"hash": "5q4Gmi0wTiP", "uri": "/contracts/5q4Gmi0wTiP#nice", "label": "Agreement Under Section 75 of the National Health Services Act 2006", "score": 21.930185318, "published": true}], "size": 1, "snippet_links": [{"key": "the-provider", "type": "definition", "offset": [6, 18]}, {"key": "in-place", "type": "clause", "offset": [37, 45]}, {"key": "the-service", "type": "clause", "offset": [87, 98]}, {"key": "in-accordance-with", "type": "clause", "offset": [112, 130]}], "hash": "48f990952667ee88a06c8fe0a5c13e39", "id": 7}, {"snippet": "Improving Outcomes Guidance (IOG): Head and Neck Cancer \u2013 NICE (2004) \u2022 Guidance on Cancer Services \u2013 Improving Outcomes in Head and Neck Cancers \u2013 The Research Evidence NICE (2004) \u2022 Improving Supportive and Palliative Care for adults with cancer \u2013 NICE (2011) \u2022 National Cancer Peer Review \u2022 National Cancer Peer Review handbook \u2013 NCPR, Nation Cancer Action Team (2011) \u2022 Manual for Cancer Services: Head and Neck Measures Version 2.0 \u2013 NCPR Nation Cancer Action Team (2011) \u2022 Manual for Cancer services Acute Oncology Measures NCPR, National Cancer Action Team (April 2011) \u2022 Manual for Cancer Services Chemotherapy Measures \u2013 NCPR, National Cancer Action Team (June 2011) Other \u2022 Chemtherapy Services in England. National Chemotherapy Advisory Group (2009) \u2022 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587: \u2587\u2587\u2587.\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587.\u2587\u2587/\u2587\u2587\u2587\u2587 \u2022 Macmillan Cancer Care: \u2587\u2587\u2587.\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587.\u2587\u2587/\u2587\u2587\u2587\u2587 General Overview Head and neck cancer refers to a group of biologically diverse cancers that start in the Upper Aerodigestive Tract (UAT), including: \u2022 Oral Cancer (mouth, lip and oral cavity) \u2022 Cancer of the larynx (voice box) \u2022 Cancer of the pharynx (throat) \u2022 Thyroid cancer (please see below) \u2022 Other head & neck cancers The majority of non thyroid head and neck cancers are squamous cell carcinomas. Head and neck cancers often spread to the lymph nodes of the neck, and this is often the first sign of the disease at the time of diagnosis.", "samples": [{"hash": "4WM9R9y8ZNq", "uri": "/contracts/4WM9R9y8ZNq#nice", "label": "NHS Standard Contract for Cancer: Head and Neck (Adult)", "score": 22.424446106, "published": true}], "size": 1, "snippet_links": [{"key": "the-research", "type": "clause", "offset": [148, 160]}, {"key": "palliative-care", "type": "clause", "offset": [209, 224]}, {"key": "for-adults", "type": "clause", "offset": [225, 235]}, {"key": "peer-review", "type": "definition", "offset": [280, 291]}, {"key": "april-2011", "type": "clause", "offset": [565, 575]}, {"key": "june-2011", "type": "clause", "offset": [665, 674]}, {"key": "advisory-group", "type": "definition", "offset": [739, 753]}, {"key": "general-overview", "type": "clause", "offset": [860, 876]}, {"key": "oral-cancer", "type": "definition", "offset": [1012, 1023]}, {"key": "the-majority", "type": "clause", "offset": [1185, 1197]}, {"key": "at-the-time", "type": "clause", "offset": [1380, 1391]}], "hash": "39fec8a4627679e0be5b4822b4858ec6", "id": 8}, {"snippet": "Psychosis and schizophrenia in adults: prevention and management. Available at: \u2587\u2587\u2587\u2587\u2587://\u2587\u2587\u2587.\u2587\u2587\u2587\u2587.\u2587\u2587\u2587.\u2587\u2587/Guidance/CG178. Accessed March 19, 2018.", "samples": [{"hash": "8uDQqklIXDX", "uri": "/contracts/8uDQqklIXDX#nice", "label": "End User License Agreement", "score": 24.0355911255, "published": true}], "size": 1, "snippet_links": [{"key": "available-at", "type": "definition", "offset": [66, 78]}], "hash": "b83c254a553fa0faf0622b6e56017bb4", "id": 9}, {"snippet": "and \u2587\u2587\u2587\u2587 acknowledge that: o it is in the interests of patients generally, and the consultees in each technology appraisal specifically, that all relevant information about technologies being appraised be put in the public domain; o NICE is under obligations of transparency and fairness to, amongst others, patients and other consultees in conducting each technology appraisal; and o the rights of the owners of the data provided to NICE must also be respected.", "samples": [{"hash": "fZtB8XmM0sM", "uri": "/contracts/fZtB8XmM0sM#nice", "label": "Data Sharing Agreement", "score": 17.4562797546, "published": true}], "size": 1, "snippet_links": [{"key": "the-interests", "type": "clause", "offset": [38, 51]}, {"key": "relevant-information", "type": "definition", "offset": [146, 166]}, {"key": "in-the-public-domain", "type": "definition", "offset": [209, 229]}, {"key": "obligations-of", "type": "clause", "offset": [247, 261]}, {"key": "transparency-and-fairness", "type": "clause", "offset": [262, 287]}, {"key": "other-consultees", "type": "clause", "offset": [321, 337]}, {"key": "the-owners", "type": "definition", "offset": [399, 409]}, {"key": "data-provided", "type": "clause", "offset": [417, 430]}], "hash": "56ecec195da1decba0e03434d062c27b", "id": 10}], "next_curs": "Ck0SR2oVc35sYXdpbnNpZGVyY29udHJhY3RzcikLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2Ig1uaWNlIzAwMDAwMDBhDKIBAmVuGAAgAA==", "clause": {"size": 57, "title": "NICE", "children": [["framework-agreement", "Framework Agreement"], ["service-support-and-communication", "Service support and communication"], ["access", "Access"], ["procurement", "Procurement"]], "parents": [["references", "REFERENCES"], ["termination", "Termination"], ["local-context", "Local context"], ["evidence-base", "Evidence base"], ["appendices-and-schedules", "APPENDICES AND SCHEDULES"]], "id": "nice", "related": [["india", "India", "India"], ["china", "CHINA", "CHINA"], ["italy", "Italy", "Italy"], ["name-of-company", "Name of Company", "Name of Company"], ["moonlighting", "Moonlighting", "Moonlighting"]], "related_snippets": [], "updated": "2025-07-24T06:49:08+00:00"}, "json": true, "cursor": ""}}